In view of the bill drafted by the Ministry of Health to allow both natural and legal persons to cultivate, process and market pharmaceuticals hemp products, the first agreement was concluded for the realization of an investment by a foreign company in our country. According to information, Aphria from Canada will make a big investment in the area of Xanthi on an area of 50,000 acres for the manufacture of industrial and pharmaceutical cannabis. A number of appointments had taken place with Deputy Minister of Development and Economy, Mr Stergios Pitsiorlas, and working groups have already been set up to undertake this investment.
Canadian interest has to do with the climate prevailing in Greece, which favors the cultivation of the plant.
Aphria is based in Ontario, Canada and is listed on the Stock Exchange.
It is a specialized company in the production of industrial and pharmaceutical cannabis despite the fact that it is established in 2013 and already has subsidiaries in the USA.
"Cannabis economy" is currently the world's fastest-growing economic activity.